Nature Reviews Cancer

Aims & Scope

Nature Reviews Cancer aims to be the premier source of reviews and commentaries for the scientific communities we serve.

We strive to publish articles that are authoritative, accessible and enhanced with clearly understandable figures, tables and other display items.

We want to provide an unparalleled service to authors, referees and readers, and we work hard to maximize the usefulness and impact of each article.

The journal publishes Research Highlights, Comments, Reviews and Perspectives relevant to cancer researchers, with our broad scope ensuring that the articles we publish reach the widest possible audience. 

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	66.8
2024	72.50

SJR (SCImago Journal Rank)

Year	Value
2024	24.378

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	527

Journal Rank

Year	Value
2024	8

Journal Citation Indicator

Year	Value
2024	10928

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The blockade of immune checkpoints in cancer immunotherapy

  Citation: 11293

  Authors: Drew M.

• MicroRNA signatures in human cancers

  Citation: 6174

  Authors: George A., Carlo M.

• Photodynamic therapy for cancer

  Citation: 5813

  Authors: Dennis E.J.G.J., Dai, Rakesh K.

• Oncomirs — microRNAs with a role in cancer

  Citation: 5722

  Authors: Aurora, Frank J.

• Targeting HIF-1 for cancer therapy

  Citation: 5386

  Authors: Gregg L.

• Epithelial–mesenchymal transitions in tumour progression

  Citation: 5267

  Authors: Jean Paul

• Cancer nanomedicine: progress, challenges and opportunities

  Citation: 4939

  Authors: Jinjun, Philip W., Richard, Omid C.

• New functions for the matrix metalloproteinases in cancer progression

  Citation: 4818

  Authors: Mikala, Zena

• The phosphatidylinositol 3-Kinase–AKT pathway in human cancer

  Citation: 4795

  Authors: Igor, Charles L.

• Multidrug resistance in cancer: role of ATP–dependent transporters

  Citation: 4512

  Authors: Michael M., Tito, Susan E.

---